Femke Mol

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Charles B. Foster, Thomas Lehrnbecher, Femke Mol et al. · Journal of Clinical Investigation · 1998 · 241 citations · Full text

Immunodeficiencies, Immunology, Genetic Epidemiology +19

Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study): an open-label, multicentre, randomised controlled trial

Femke Mol, Norah M. van Mello, Annika Strandell et al. · The Lancet · 2014 · 198 citations

Gynecologic Surgery, Salpingotomy Versus Salpingectomy, Gynecological Surgery +9

Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial

Janine G Smit, Jenneke C. Kasius, Marinus J.C. Eijkemans et al. · The Lancet · 2016 · 155 citations

Hysteroscopy, Infertility, Gynecological Surgery +9

An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus

Charles B. Foster, Thomas Lehrnbecher, Susan Samuels et al. · Blood · 2000 · 143 citations

Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison

Norah M. van Mello, Femke Mol, Harold R Verhoeve et al. · Human Reproduction · 2012 · 135 citations · Full text